TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/21/11 20:13 | 4/20/11 | LJPC | La Jolla Pharmaceutical Co | DE | Health | BioPrd | Biological Products, (No Diag | Sloan Gail A | CA | O | CFO | S | 0 | 1.00 | 0 | 0 | -9 | 1 | D | ||||||||||||||
8/7/09 15:53 | 8/6/09 | LJPC | La Jolla Pharmaceutical Co | DE | Health | BioPrd | Biological Products, (No Diag | Sloan Gail A | CA | O | VP of Fi | S | 0 | 0.1900 | 0 | -2 | -100 | 0 | D | ||||||||||||||
6/25/09 20:15 | 6/25/09 | LJPC | La Jolla Pharmaceutical Co | DE | Health | BioPrd | Biological Products, (No Diag | Sloan Gail A | CA | O | VP of Fi | S | 0 | 0.1800 | 0 | -2 | -55 | 2 | I | ||||||||||||||
6/19/09 17:35 | 6/18/09 | LJPC | La Jolla Pharmaceutical Co | DE | Health | BioPrd | Biological Products, (No Diag | Sloan Gail A | CA | O | VP of Fi | S | -1 | 0.2000 | 0 | -5 | -55 | 4 | D | ||||||||||||||
4/14/04 18:04 | 4/12/04 | LJPC | La Jolla Pharmaceutical Co | DE | Health | BioPrd | Biological Products, (No Diag | Sloan Gail A | CA | O | VP of Fi | P.d | 1 | 2.72 | 0 | 0 | 2 | 13 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |